Search
 
Site Selectivity

After being swallowed, injected, inhaled, or absorbed through the skin, most drugs enter the bloodstream and circulate throughout the body. Some drugs are administered directly to the area where they are wanted—for example, to the eyes in eyedrops. The drugs then interact with cells or tissues where they produce their intended effects (target sites). Some drugs are relatively nonselective. They affect many different tissues or organs. For example, atropineSome Trade Names
ATROPEN
, a drug given to relax muscles in the digestive tract, may also relax muscles in the eyes and in the respiratory tract. Other drugs are relatively selective. For example, nonsteroidal anti-inflammatory drugs (NSAIDs), such as aspirinSome Trade Names
BAYER
and ibuprofenSome Trade Names
ADVIL MOTRIN
(see Pain: Nonopioid Analgesics), target any area where inflammation is present. Still other drugs are highly selective. They affect mainly a single organ or system. For example, digoxinSome Trade Names
LANOXIN
, a drug given to manage heart failure, affects mainly the heart, increasing its pumping efficiency. Sleep aids target certain nerve cells of the brain.

How do drugs know where to exert their effects? The answer involves how they interact with cells or substances such as enzymes.

Receptors on Cells

On their surface, most cells have many different types of receptors. A receptor is a molecule with a specific three-dimensional structure, which allows only substances that fit precisely to attach to it—as a key fits in its lock. Receptors enable natural (originating in the body) substances outside the cell, such as neurotransmitters and hormones, to influence the activity of the cell. That influence may be to stimulate or inhibit a process inside the cell. Drugs tend to mimic these natural substances and thus use receptors in the same way. For example, morphineSome Trade Names
MS CONTIN ORAMORPH
and related pain-relieving drugs act on or affect the same receptors in the brain used by endorphins, which are substances produced by the body to help control pain. Some drugs attach to only one type of receptor. Other drugs, like a master key, can attach to several types of receptors throughout the body. A drug's selectivity can often be explained by how selectively it attaches to receptors.

A Perfect Fit

A receptor on the cell's surface has a three-dimensional structure that allows a specific substance, such as a drug, hormone, or neurotransmitter, to bind to it because the substance has a three-dimensional structure that perfectly fits the receptor, as a key fits a lock.

Agonists and Antagonists: Drugs that target receptors are classified as agonists or antagonists. Agonist drugs activate, or stimulate, their receptors, triggering a response that increases or decreases the cell's activity. Antagonist drugs block the access or attachment of the body's natural agonists, usually neurotransmitters, to their receptors and thereby prevent or reduce cell responses to natural agonists.

Agonist and antagonist drugs can be used together in patients with asthma. For example, albuterolSome Trade Names
PROVENTIL-HFA VENTOLIN HFA
can be used with ipratropiumSome Trade Names
ATROVENT
. AlbuterolSome Trade Names
PROVENTIL-HFA VENTOLIN HFA
, an agonist, attaches to specific (adrenergic) receptors on cells in the respiratory tract, causing relaxation of smooth muscle cells and thus widening of the airways (bronchodilation). IpratropiumSome Trade Names
ATROVENT
, an antagonist, attaches to other (cholinergic) receptors, blocking the attachment of acetylcholine, a neurotransmitter that causes contraction of smooth muscle cells and thus narrowing of the airways (bronchoconstriction). Both drugs widen the airways (and make breathing easier) but in different ways.

Beta-blockers, such as propranololSome Trade Names
INDERAL
, are a widely used group of antagonists. These drugs are used to treat high blood pressure, angina (chest pain caused by an inadequate blood supply to the heart muscle), and certain abnormal heart rhythms and to prevent migraines. They block or reduce stimulation of the heart by the agonist hormones epinephrine (adrenaline) and norepinephrine (noradrenaline), which are released during stress. Antagonists such as beta-blockers are most effective when the concentration of the agonist is high in a specific part of the body. Similar to the way a roadblock stops more vehicles during the 5:00 pm rush hour than at 3:00 am, beta-blockers, given in doses that have little effect on normal heart function, may have a greater effect during sudden surges of hormones released during stress and thereby protect the heart from excess stimulation.

Targets in The Body: Cell Receptors

Certain natural substances in the body, such as neurotransmitters and hormones, target specific receptors on the surface of cells. When these substances bind with the receptor on a cell, they stimulate that receptor to perform its function, which is to produce or to inhibit a specific action in the cell. Drugs can also target and bind with these receptors.

Some drugs act as agonists, stimulating the receptor in the same way that the body's natural substances do. Others act as antagonists, blocking the action of the natural substance on the receptor. Each type of receptor has many subtypes, and drugs may act on one or several subtypes of receptors.

Type of Receptor

Body's Natural Agonist

Resulting Action

Drugs That Target the Receptor

Adrenergic

Alpha1

Epinephrine and norepinephrine

“Fight-or-flight” reactions: Constriction of the blood vessels in the skin, digestive tract, and urinary tract

Breakdown of glucose in the liver (releasing energy)

Decrease in activity of the stomach and intestines

Contraction of smooth muscle in the genital and urinary organs

Agonist: Methoxamine and phenylephrineSome Trade Names
PROMETH VC PLAIN

Antagonist: DoxazosinSome Trade Names
CARDURA
, prazosinSome Trade Names
MINIPRESS
, tamsulosinSome Trade Names
FLOMAX
, and terazosinSome Trade Names
HYTRIN

Alpha2

Epinephrine and norepinephrine

A decrease in insulin secretion, in the clumping of platelets, in the constriction of blood vessels in the skin and intestines, and in the release of norepinephrine from nerves

Agonist: ClonidineSome Trade Names
CATAPRES

Antagonist: YohimbineSome Trade Names
YOCON

Beta1

Epinephrine and norepinephrine

An increase in heart rate, in the force of heart contraction, and in secretion of renin (a hormone involved in controlling blood pressure)

Agonist: Dobutamine and isoproterenolSome Trade Names
ISUPREL

Antagonist: Beta-blockers (used to treat hypertension and heart disease), such as atenololSome Trade Names
TENORMIN
and metoprololSome Trade Names
LOPRESSOR TOPROL-XL

Beta2

Epinephrine and norepinephrine

Dilation of smooth muscle in the blood vessels, airways, digestive tract, and urinary tract

Breakdown of glycogen in skeletal muscles (releasing glucose for energy)

Agonist: AlbuterolSome Trade Names
PROVENTIL-HFA VENTOLIN HFA
, isoetharine, and terbutaline

Antagonist: PropranololSome Trade Names
INDERAL

Cholinergic

Muscarinic

Acetylcholine

A decrease in heart rate and the force of the heart's contraction

Constriction of airways

Dilation of blood vessels throughout the body

Increase in activity of the stomach, intestines, bladder, and salivary, lacrimal, and sweat glands

Agonist: BethanecholSome Trade Names
URECHOLINE
and carbacholSome Trade Names
MIOSTAT

Antagonist: AtropineSome Trade Names
ATROPEN
, ipratropiumSome Trade Names
ATROVENT
, and scopolamineSome Trade Names
TRANSDERM SCOP

Nicotinic

Acetylcholine

Contraction of skeletal muscles

Agonist: None commonly used

Antagonist: Atracurium, pancuronium, and tubocurarine

Histaminergic

H1

Histamine

Production of an allergic response

Contraction of muscles in the airways and digestive tract

Dilation of small blood vessels

Drowsiness (sedation)

Agonist: None commonly used

Antagonist: CetirizineSome Trade Names
ZYRTEC
, chlorpheniramineSome Trade Names
CHLOR-TRIMETON
, clemastineSome Trade Names
TAVIST-1
, diphenhydramineSome Trade Names
BENADRYL
, fexofenadineSome Trade Names
ALLEGRA
, and loratadineSome Trade Names
CLARITIN

H2

Histamine

Stimulation of stomach secretions

Agonist: None commonly used

Antagonist: CimetidineSome Trade Names
TAGAMET
, famotidineSome Trade Names
PEPCID
, nizatidineSome Trade Names
AXID
, and ranitidineSome Trade Names
ZANTAC

Serotoninergic

Serotonin

Constriction of blood vessels within the brain

Stimulation of activity (motility) in the digestive tract

Contraction of blood vessels

Effects on sleep, memory, sensory perception, temperature regulation, mood, appetite, and hormone secretion

Partial agonist: BuspironeSome Trade Names
BUSPAR

Agonist*: Sumitriptan and zomitriptan

Antagonist: Methysergide and ondansetronSome Trade Names
ZOFRAN

Dopaminergic

Dopamine

Involvement in movement, mood, thinking, learning, and reward-seeking

Also increases blood flow to the kidneys, which allows for increased urine excretion

Agonist: PramipexoleSome Trade Names
MIRAPEX
and ropiniroleSome Trade Names
REQUIP

Antagonist: OlanzapineSome Trade Names
ZYPREXA
and risperidoneSome Trade Names
RISPERDAL

*Antidepressants called serotonin reuptake inhibitors (SSRIs) act by enhancing the effects of serotonin but are not agonists (they do not act on the serotonin receptor).

Enzymes

Instead of receptors, some drugs target enzymes, which regulate the rate of chemical reactions. Drugs that target enzymes are classified as inhibitors or activators (inducers). For example, the cholesterol-lowering drug lovastatinSome Trade Names
MEVACOR
inhibits an enzyme called HMG-CoA reductase, which is critical in the body's production of cholesterol. A side effect of the antibiotic rifampinSome Trade Names
RIFADIN RIMACTANE
is the activation of the enzymes involved in metabolizing oral contraceptives. When women who are taking an oral contraceptive also take rifampinSome Trade Names
RIFADIN RIMACTANE
, the contraceptive is metabolized (that is, broken down into inactive components) and removed from the body more quickly than usual and may therefore be ineffective.

Last full review/revision November 2007 by Angela Cafiero Moroney, PharmD

Pronunciations

Back to Top

Previous: Definition of Drug Dynamics

Next: Drug Action

Audio
Figures
Photographs
Pronunciations
Tables
Videos

Copyright     © 2010-2011 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Whitehouse Station, N.J., U.S.A.    Privacy    Terms of Use